STOCK TITAN

Synopsys Inc Financials

SNPS
Source SEC Filings (10-K/10-Q) Updated Feb 25, 2026 Currency USD FYE October

This page shows Synopsys Inc (SNPS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 54 / 100
Financial Profile 54/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
51

Synopsys Inc has an operating margin of 13.0%, meaning the company retains $13 of operating profit per $100 of revenue. This results in a moderate score of 51/100, indicating healthy but not exceptional operating efficiency. This is down from 22.1% the prior year.

Growth
59

Synopsys Inc's revenue surged 15.1% year-over-year to $7.1B, reflecting rapid business expansion. This strong growth earns a score of 59/100.

Leverage
95

Synopsys Inc carries a low D/E ratio of 0.33, meaning only $0.33 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 95/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
23

Synopsys Inc's current ratio of 1.36 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 23/100, which could limit financial flexibility.

Cash Flow
73

Synopsys Inc converts 19.1% of revenue into free cash flow ($1.3B). This strong cash generation earns a score of 73/100.

Returns
21

Synopsys Inc generates a 4.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 21/100. This is down from 24.3% the prior year.

Altman Z-Score Safe
3.28

Synopsys Inc scores 3.28, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($75.8B) relative to total liabilities ($16.7B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Weak
3/9

Synopsys Inc passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.14x

For every $1 of reported earnings, Synopsys Inc generates $1.14 in operating cash flow ($1.5B OCF vs $1.3B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
2.0x

Synopsys Inc earns $2.0 in operating income for every $1 of interest expense ($914.9M vs $446.7M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$7.1B
YoY+15.1%
5Y CAGR+13.9%
10Y CAGR+12.1%

Synopsys Inc generated $7.1B in revenue in fiscal year 2025. This represents an increase of 15.1% from the prior year.

EBITDA
$1.6B
YoY-4.6%
5Y CAGR+13.7%
10Y CAGR+12.7%

Synopsys Inc's EBITDA was $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 4.6% from the prior year.

Net Income
$1.3B
YoY-41.1%
5Y CAGR+14.9%
10Y CAGR+19.4%

Synopsys Inc reported $1.3B in net income in fiscal year 2025. This represents a decrease of 41.1% from the prior year.

EPS (Diluted)
$8.04
YoY-44.6%
5Y CAGR+13.5%
10Y CAGR+18.8%

Synopsys Inc earned $8.04 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 44.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$1.3B
YoY+6.4%
5Y CAGR+10.0%
10Y CAGR+12.7%

Synopsys Inc generated $1.3B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 6.4% from the prior year.

Cash & Debt
$2.1B
YoY-41.7%
5Y CAGR+15.8%
10Y CAGR+13.8%

Synopsys Inc held $2.1B in cash against $10.0B in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
191M
YoY+23.8%
5Y CAGR+4.6%
10Y CAGR+2.4%

Synopsys Inc had 191M shares outstanding in fiscal year 2025. This represents an increase of 23.8% from the prior year.

Margins & Returns

Gross Margin
77.0%
YoY-2.7pp
5Y CAGR-1.5pp
10Y CAGR+0.1pp

Synopsys Inc's gross margin was 77.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.7 percentage points from the prior year.

Operating Margin
13.0%
YoY-9.2pp
5Y CAGR-3.9pp
10Y CAGR+1.1pp

Synopsys Inc's operating margin was 13.0% in fiscal year 2025, reflecting core business profitability. This is down 9.2 percentage points from the prior year.

Net Margin
18.9%
YoY-18.1pp
5Y CAGR+0.9pp
10Y CAGR+8.8pp

Synopsys Inc's net profit margin was 18.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 18.1 percentage points from the prior year.

Return on Equity
4.4%
YoY-20.0pp
5Y CAGR-9.3pp
10Y CAGR-3.2pp

Synopsys Inc's ROE was 4.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 20.0 percentage points from the prior year.

Capital Allocation

R&D Spending
$2.5B
YoY+19.1%
5Y CAGR+14.2%
10Y CAGR+12.3%

Synopsys Inc invested $2.5B in research and development in fiscal year 2025. This represents an increase of 19.1% from the prior year.

Share Buybacks
$0

Synopsys Inc spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
$169.5M
YoY+21.5%
5Y CAGR+1.8%
10Y CAGR+6.9%

Synopsys Inc invested $169.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 21.5% from the prior year.

SNPS Income Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Revenue $951.5M-60.5% $2.4B+6.8% $2.3B+29.6% $1.7B+8.4% $1.6B+10.2% $1.5B-11.0% $1.6B+7.2% $1.5B
Cost of Revenue $242.4M-62.0% $637.4M-2.6% $654.7M+72.0% $380.6M+19.5% $318.3M+17.9% $270.0M-28.0% $375.0M+29.0% $290.7M
Gross Profit $709.1M-60.0% $1.8B+10.7% $1.6B+17.7% $1.4B+5.7% $1.3B+8.5% $1.2B-6.0% $1.3B+2.1% $1.2B
R&D Expenses $715.0M0.0% $715.0M-4.3% $746.8M+19.4% $625.3M+12.9% $554.0M+0.1% $553.2M-0.3% $554.8M+9.0% $508.9M
SG&A Expenses $182.7M0.0% $182.7M-1.5% $185.5M-33.9% $280.6M+105.5% $136.5M-18.3% $167.1M-2.9% $172.0M+14.4% $150.4M
Operating Income $203.0M0.0% $203.0M+67.3% $121.4M-26.5% $165.3M-56.1% $376.4M+49.5% $251.8M-19.0% $310.8M-13.7% $360.2M
Interest Expense $162.7M0.0% $162.7M-16.5% $194.8M+32.9% $146.5M+55.3% $94.3M+746.9% $11.1M-33.3% $16.7M+42.2% $11.7M
Income Tax $14.3M0.0% $14.3M-78.9% $68.1M+228.5% -$53.0M-212.3% $47.2M+849.6% -$6.3M-110.1% $62.1M+302.1% -$30.7M
Net Income $65.0M0.0% $65.0M-85.5% $448.7M+85.0% $242.5M-29.8% $345.3M+16.8% $295.7M-73.5% $1.1B+173.0% $408.1M
EPS (Diluted) $0.340.0% $0.34 N/A $1.50-32.1% $2.21+16.9% $1.89 N/A $2.61

SNPS Balance Sheet

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Total Assets $47.2B0.0% $47.2B-2.0% $48.2B0.0% $48.2B+103.0% $23.8B+82.2% $13.0B-0.2% $13.1B+12.2% $11.6B
Current Assets $5.4B0.0% $5.4B-10.6% $6.0B+7.4% $5.6B-66.8% $16.9B+166.9% $6.3B-2.3% $6.5B+26.2% $5.1B
Cash & Equivalents $2.1B0.0% $2.1B-26.3% $2.9B+14.3% $2.5B-82.1% $14.1B+286.4% $3.7B-6.2% $3.9B+111.8% $1.8B
Inventory $393.2M0.0% $393.2M+7.7% $365.2M-4.4% $382.1M-3.4% $395.3M-4.8% $415.2M+14.7% $361.8M-6.3% $386.0M
Accounts Receivable $1.6B0.0% $1.6B+9.0% $1.5B+8.1% $1.4B+38.9% $1.0B+12.3% $892.6M-4.5% $934.5M+16.1% $805.2M
Goodwill $26.9B0.0% $26.9B-0.1% $26.9B-0.2% $26.9B+678.5% $3.5B+0.8% $3.4B-0.4% $3.4B+0.1% $3.4B
Total Liabilities $16.7B0.0% $16.7B-16.1% $19.9B-3.5% $20.6B+49.0% $13.8B+270.5% $3.7B-7.8% $4.1B+3.8% $3.9B
Current Liabilities $3.9B0.0% $3.9B+5.9% $3.7B+8.1% $3.4B+43.1% $2.4B+2.0% $2.4B-11.0% $2.7B+4.5% $2.5B
Long-Term Debt $10.0B0.0% $10.0B-25.6% $13.5B-6.0% $14.3B+42.8% $10.0B+70418.2% $14.2M-8.9% $15.6M0.0% $15.6M
Total Equity $30.5B0.0% $30.5B+7.8% $28.3B+2.6% $27.6B+178.5% $9.9B+6.6% $9.3B+3.5% $9.0B+16.6% $7.7B
Retained Earnings $10.4B0.0% $10.4B+0.6% $10.3B+4.5% $9.9B+2.5% $9.6B+3.7% $9.3B+3.3% $9.0B+14.0% $7.9B

SNPS Cash Flow Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Operating Cash Flow $856.8M0.0% $856.8M+33.9% $639.7M-4.7% $671.0M+143.7% $275.4M+508.2% -$67.5M-112.0% $562.8M+23.6% $455.4M
Capital Expenditures $35.3M0.0% $35.3M+2.2% $34.5M-10.5% $38.6M-30.6% $55.6M+36.5% $40.7M+96.4% $20.7M-48.2% $40.0M
Free Cash Flow $821.5M0.0% $821.5M+35.7% $605.2M-4.3% $632.4M+187.7% $219.8M+303.2% -$108.2M-120.0% $542.1M+30.5% $415.4M
Investing Cash Flow -$36.5M0.0% -$36.5M-106.5% $564.4M+103.4% -$16.5B-21816.7% $76.0M+445.7% -$22.0M-101.5% $1.4B+2782.5% -$53.8M
Financing Cash Flow -$1.6B0.0% -$1.6B-89.4% -$835.9M-119.7% $4.2B-58.0% $10.1B+7218.3% -$141.8M-571.3% $30.1M+153.0% -$56.8M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A $0 $0

SNPS Financial Ratios

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Gross Margin 74.5%+1.0pp 73.5%+2.6pp 71.0%-7.2pp 78.1%-2.0pp 80.2%-1.3pp 81.5%+4.4pp 77.1%-3.9pp 81.0%
Operating Margin 21.3%+12.9pp 8.4%+3.0pp 5.4%-4.1pp 9.5%-14.0pp 23.5%+6.2pp 17.3%-1.7pp 19.0%-4.6pp 23.6%
Net Margin 6.8%+4.1pp 2.7%-17.2pp 19.9%+6.0pp 13.9%-7.6pp 21.5%+1.2pp 20.3%-47.8pp 68.1%+41.4pp 26.7%
Return on Equity 0.2%0.0pp 0.2%-1.4pp 1.6%+0.7pp 0.9%-2.6pp 3.5%+0.3pp 3.2%-9.2pp 12.4%+7.1pp 5.3%
Return on Assets 0.1%0.0pp 0.1%-0.8pp 0.9%+0.4pp 0.5%-1.0pp 1.5%-0.8pp 2.3%-6.3pp 8.5%+5.0pp 3.5%
Current Ratio 1.360.0 1.36-0.3 1.620.0 1.62-5.4 7.02+4.3 2.68+0.2 2.44+0.4 2.02
Debt-to-Equity 0.330.0 0.33-0.1 0.48-0.0 0.52-0.5 1.01+1.0 0.000.0 0.000.0 0.00
FCF Margin 86.3%+52.2pp 34.1%+7.3pp 26.8%-9.5pp 36.4%+22.6pp 13.7%+21.1pp -7.4%-40.6pp 33.1%+5.9pp 27.2%

Similar Companies

Frequently Asked Questions

Synopsys Inc (SNPS) reported $7.1B in total revenue for fiscal year 2025. This represents a 15.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Synopsys Inc (SNPS) revenue grew by 15.1% year-over-year, from $6.1B to $7.1B in fiscal year 2025.

Yes, Synopsys Inc (SNPS) reported a net income of $1.3B in fiscal year 2025, with a net profit margin of 18.9%.

Synopsys Inc (SNPS) reported diluted earnings per share of $8.04 for fiscal year 2025. This represents a -44.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Synopsys Inc (SNPS) had EBITDA of $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Synopsys Inc (SNPS) had $2.1B in cash and equivalents against $10.0B in long-term debt.

Synopsys Inc (SNPS) had a gross margin of 77.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Synopsys Inc (SNPS) had an operating margin of 13.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Synopsys Inc (SNPS) had a net profit margin of 18.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Synopsys Inc (SNPS) has a return on equity of 4.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Synopsys Inc (SNPS) generated $1.3B in free cash flow during fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Synopsys Inc (SNPS) generated $1.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Synopsys Inc (SNPS) had $47.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Synopsys Inc (SNPS) invested $169.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Synopsys Inc (SNPS) invested $2.5B in research and development during fiscal year 2025.

Synopsys Inc (SNPS) had 191M shares outstanding as of fiscal year 2025.

Synopsys Inc (SNPS) had a current ratio of 1.36 as of fiscal year 2025, which is considered adequate.

Synopsys Inc (SNPS) had a debt-to-equity ratio of 0.33 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Synopsys Inc (SNPS) had a return on assets of 2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Synopsys Inc (SNPS) has an Altman Z-Score of 3.28, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Synopsys Inc (SNPS) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Synopsys Inc (SNPS) has an earnings quality ratio of 1.14x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Synopsys Inc (SNPS) has an interest coverage ratio of 2.0x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Synopsys Inc (SNPS) scores 54 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top